Truist Financial Forecasts Strong Price Appreciation for National Health Investors (NYSE:NHI) Stock

National Health Investors (NYSE:NHI) had its price objective raised by equities researchers at Truist Financial from $76.00 to $77.00 in a research note issued on Monday,Benzinga reports. The firm currently has a “hold” rating on the real estate investment trust’s stock. Truist Financial’s target price suggests a potential upside of 7.12% from the company’s previous close.

Separately, Wedbush reissued an “outperform” rating and set a $88.00 price objective on shares of National Health Investors in a report on Monday, March 17th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $85.75.

National Health Investors Trading Up 0.1%

Shares of NHI stock opened at $71.88 on Monday. National Health Investors has a 12 month low of $64.00 and a 12 month high of $86.13. The company has a market cap of $3.36 billion, a PE ratio of 24.70, a price-to-earnings-growth ratio of 4.42 and a beta of 0.75. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92. The business’s 50 day moving average is $73.65 and its two-hundred day moving average is $72.05.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Monday, May 5th. The real estate investment trust reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.13 by $0.02. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The business had revenue of $68.87 million for the quarter, compared to the consensus estimate of $85.13 million. During the same quarter last year, the company posted $1.10 earnings per share. National Health Investors’s quarterly revenue was up 9.6% on a year-over-year basis. Equities analysts predict that National Health Investors will post 4.41 EPS for the current year.

Institutional Investors Weigh In On National Health Investors

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Smartleaf Asset Management LLC increased its position in shares of National Health Investors by 49.8% in the first quarter. Smartleaf Asset Management LLC now owns 442 shares of the real estate investment trust’s stock valued at $33,000 after acquiring an additional 147 shares during the last quarter. Loomis Sayles & Co. L P grew its stake in National Health Investors by 42.0% in the fourth quarter. Loomis Sayles & Co. L P now owns 639 shares of the real estate investment trust’s stock valued at $44,000 after purchasing an additional 189 shares in the last quarter. GF Fund Management CO. LTD. acquired a new position in shares of National Health Investors during the 4th quarter worth approximately $58,000. Jones Financial Companies Lllp raised its stake in shares of National Health Investors by 781.2% during the 4th quarter. Jones Financial Companies Lllp now owns 890 shares of the real estate investment trust’s stock worth $62,000 after purchasing an additional 789 shares in the last quarter. Finally, Venturi Wealth Management LLC acquired a new stake in shares of National Health Investors in the 4th quarter valued at approximately $63,000. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.